戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n alleviate gastric lesions related to acute mountain sickness.
2  becomes excessive and can result in chronic mountain sickness.
3 this disorder and the much more common acute mountain sickness.
4 nnaire Score to assess the severity of acute mountain sickness.
5 th worse cardiopulmonary function in chronic mountain sickness.
6 ithstands the negative influences of chronic mountain sickness.
7  to high-altitude pathologies, such as acute mountain sickness.
8                                        Acute mountain sickness (AMS) affects more than 25% of individ
9                                        Acute mountain sickness (AMS) and high-altitude pulmonary oede
10 t altitude did not predict symptoms of acute mountain sickness (AMS) or development of high-altitude
11 tude are not predictive of symptoms of acute mountain sickness (AMS) or development of high-altitude
12  exposure to high altitude, the CBF in acute mountain sickness (AMS) subjects was higher (P < 0.05),
13 (BBB) function would be compromised in acute mountain sickness (AMS) subsequent to a hypoxia-mediated
14 ncluding high altitude headache (HAH), acute mountain sickness (AMS), and high altitude cerebral oede
15 h-altitude illnesses (HAIs), including acute mountain sickness (AMS), high-altitude cerebral oedema (
16  be associated with the development of acute mountain sickness (AMS), this association has not been s
17 ividuals with symptoms consistent with acute mountain sickness (AMS).
18 xygen saturation and the occurrence of acute mountain sickness and discomfort as measured by response
19 ent residents or highlanders include chronic mountain sickness and high-altitude pulmonary hypertensi
20 reater tendency to develop symptoms of acute mountain sickness and high-altitude pulmonary oedema upo
21 ed to reduce their susceptibility to chronic mountain sickness and to be introduced in the gene pool
22 cessive erythrocytosis, Andeans with chronic mountain sickness, appear to have phenotypically adapted
23               There is new research on acute mountain sickness associated with inflammation with rele
24 Acetazolamide (ACZ) is used to prevent acute mountain sickness at altitude.
25 sufficient to affect the occurrence of acute mountain sickness but did contribute to the increased fr
26 altitude (VAS[O]; various thresholds), Acute Mountain Sickness-Cerebral score (AMS-C; >/=0.7 indicate
27 erall feeling of sickness at altitude, Acute Mountain Sickness-Cerebral, and clinical functional scor
28                                      Chronic mountain sickness (CMS) can affect high-altitude residen
29            We observed patients with chronic mountain sickness (CMS) in our clinic who developed prog
30                                      Chronic mountain sickness (CMS) is a maladaptation syndrome enco
31                     The diagnosis of chronic mountain sickness (CMS) is based on a score including 7
32 aladapted, with a condition known as chronic mountain sickness (CMS) or Monge disease.
33 titude dwellers, including some with chronic mountain sickness (CMS), which is characterized by exces
34  hallmark of patients suffering from chronic mountain sickness (CMS, also known as Monge's disease) a
35 rait in some high-altitude dwellers (chronic mountain sickness [CMS] or Monge's disease) but not othe
36 s with (n = 19) and without (n = 17) chronic mountain sickness, documenting exercise capacity and cha
37                At rest, Andeans with chronic mountain sickness had a substantial plasma volume contra
38 landers going to high altitude include acute mountain sickness, high-altitude pulmonary edema, and hi
39 art failure is a hallmark feature of chronic mountain sickness in maladapted populations living at hi
40                      The prevalence of acute mountain sickness increases with higher altitudes.
41 ed mortality due to heart failure in chronic mountain sickness most likely reduces fitness.
42                                 Severe acute mountain sickness occurred in 314 (23.7%), high-altitude
43                               Overall, acute mountain sickness occurred in 7.4% of the participants,
44                                        Acute mountain sickness occurs in some unacclimatized persons
45 entrations are a cardinal feature of chronic mountain sickness offering one plausible mechanism for s
46 , FASLG and SMAD7 were associated with acute mountain sickness scores and peripheral oxygen saturatio
47  fact that Barcroft was suffering from acute mountain sickness when he made it!
48 r, Andean highlanders suffering from chronic mountain sickness, which is characterized by an excessiv
49 cute disease, high altitude involves chronic mountain sickness with new knowledge of associated cardi